Jade Biosciences Inc — Quarterly Balance Sheet (NASDAQ:JBIO)

Financials

Total revenue ————— — Gross profit ————— — Operating expenses 17.41 M8.85 M3.39 M27.78 M27.4 M 67.41 M Selling/general/admin expenses 7.08 M10.57 M3.39 M5.23 M5.39 M 24.58 M Research & development 10.33 M-1.72 M20.08 M22.55 M22.01 M — Operating income 17.41 M8.85 M3.39 M27.78 M27.4 M 67.41 M Non-Operating Income, Total 1.17 M-1.37 M869 K4.36 M2.23 M 6.08 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 1.16 M0867 K4.36 M2.2 M 7.42 M Unusual income/expense 10 K-1.37 M2 000—28 K — Pretax income 18.58 M7.47 M4.26 M32.13 M29.63 M 73.49 M Equity in earnings ————— — Taxes —36.94 M—00 — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 16.24 M5.39 M2.52 M32.13 M25.18 M 65.22 M Discontinued operations ————— — Net income 16.24 M5.39 M2.52 M32.13 M25.18 M 65.22 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 16.24 M5.39 M2.52 M24.55 M19.09 M 51.55 M Basic earnings per share (Basic EPS) -0.564.41-0.09-0.86-0.48 2.98 Diluted earnings per share (Diluted EPS) -0.564.41-0.09-0.86-0.48 2.98 Average basic shares outstanding 28.86 M28.58 M28.99 M28.43 M39.58 M 125.58 M Diluted shares outstanding 28.86 M28.58 M28.99 M28.43 M39.58 M 125.58 M EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 218 K8 0004 0001 00012 K 25 K